-Reuters
NRx Pharma Announces Receipt of Positive Nasdaq Listing Determination
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) ("NRx" or the "Company"), a clinical-stage biopharmaceutical company developing therapies for suicidal depression, chronic pain, and PTSD, today announced that